Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions

被引:8
|
作者
Toz, Emrah [1 ]
Ozcan, Aykut [1 ]
Balsak, Deniz [2 ]
Avci, Muhittin Eftal [3 ]
Eraslan, Arzu Gorgulu [4 ]
Balci, Didem Didar [5 ]
机构
[1] Izmir Tepecik Teaching & Res Hosp, Dept Gynecol & Obstet, Izmir, Turkey
[2] Istanbul Halic Univ, Dept Gynecol & Obstet, Istanbul, Turkey
[3] Kanuni Sultan Suleyman Training & Res Hosp, Dept Gynecol & Obstet, Istanbul, Turkey
[4] Izmir Kent Hosp, Dept Dermatol, Izmir, Turkey
[5] Izmir Tepecik Teaching & Res Hosp, Dept Dermatol, Izmir, Turkey
关键词
Prophylactic oophorectomy; Premenopausal women; Skin aging; POSTMENOPAUSAL WOMEN; OVARIAN CONSERVATION; HORMONE-THERAPY; TIME;
D O I
10.1097/GME.0000000000000511
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective:This study aimed to assess the effects of hysterectomy and bilateral salpingo-oophorectomy (BSO)compared with the effects of hysterectomy aloneon skin aging in premenopausal women undergoing hysterectomy for benign conditions.Methods:One hundred thirty-five premenopausal women who underwent hysterectomy with BSO were compared with a control group of women who underwent hysterectomy alone based on skin parameters (including wrinkling, laxity/sagging, and texture/dryness) and Skindex-29 questionnaire scores. The inclusion criteria were as follows: aged between 40 and 50 years, follicle-stimulating hormone level lower than 40mIU/mL, undergoing hysterectomy with or without BSO for benign conditions, and not receiving estrogen or progesterone treatment. The exclusion criteria were as follows: adrenocortical hyperplasia or Cushing's syndrome; use of corticosteroids for autoimmune diseases; malignancy, connective tissue diseases (eg, Ehlers-Danlos syndrome), or dermatological diseases (eg, lichen sclerosus); or regular use of medications known to interfere with the condition of the skin.Results:All skin parameters in the hysterectomy group and the hysterectomy with BSO group worsened on weeks 24 and 48. Laxity/sagging and texture/dryness scores on weeks 24 and 48 were significantly worse in the BSO group; laxity/sagging and texture/dryness scores continued to worsen between 24 and 48 weeks. Scores for the Skindex-29 questionnaire emotion and symptom subscales were significantly higher in the BSO group compared with the non-BSO group.Conclusions:Prophylactic BSO during hysterectomy is a significant independent risk factor for worsening skin laxity/sagging and texture/dryness in premenopausal women undergoing hysterectomy for benign conditions. Prophylactic BSO in the presence of dermatological conditions is also associated with reduced quality of life.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 50 条
  • [41] Histopathological Result after prophylactic bilateral Salpingo-Oophorectomy in Women with BRCA1/2 Mutation - single center Experience
    Ehmann, S.
    Ramspott, J. P.
    du Bois, A.
    Harter, P.
    Heitz, F.
    Schneider, S.
    Baert, T.
    Pauly, N.
    Traut, A.
    Heikaus, S.
    Ataseven, B.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E187 - E188
  • [42] Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation
    Guidozzi, F.
    CLIMACTERIC, 2016, 19 (05) : 419 - 422
  • [43] A retrospective review of patient-reported outcomes on the impact on quality of life in patients undergoing total abdominal hysterectomy and bilateral salpingo-oophorectomy for endometriosis
    Tan, Bee K.
    Maillou, Kate
    Mathur, Rajneesh S.
    Prentice, Andrew
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (02) : 533 - 538
  • [44] Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk-Reductive Bilateral Salpingo-Oophorectomy
    Poon, C.
    Hyde, S.
    Grant, P.
    Newman, M.
    Ireland-Jenkins, K.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2016, 56 : 52 - 52
  • [45] Ovarian cancer incidence and death in average-risk women undergoing bilateral oophorectomy at benign hysterectomy
    Cusimano, Maria
    Ferguson, Sarah
    Chiu, Maria
    Moineddin, Rahim
    Aktar, Suriya
    Liu, Ning
    Baxter, Nancy
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S224 - S224
  • [46] INCIDENCE OF STIC AND P53 SIGNATURES IN WOMEN UNDERGOING RISK REDUCING BILATERAL SALPINGO-OOPHORECTOMY AT AN ONCOLOGY CENTRE IN UK
    Aggarwal, I.
    Attygalle, A.
    Hazell, S.
    Ind, T.
    Barton, D.
    Butler, J.
    Nobbenhuis, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 386 - 386
  • [47] Impact of a personal history of breast cancer on bone mineral density among women with a BRCA1 or BRCA2 mutation undergoing prophylactic bilateral salpingo-oophorectomy
    Kotsopoulos, Joanne
    Hall, Elizabeth
    Finch, Amy
    Rosen, Barry
    Murphy, Joan
    Narod, Steven A.
    Cheung, Angela M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 393 - 393
  • [48] Trends towards Decreased Cortical Thickness and Increased Cortical Porosity in a One-Year Pilot Study of Premenopausal BRCA Mutation Carriers Undergoing Prophylactic Salpingo-Oophorectomy
    Cheung, Angela
    Dwyer, Madeline
    Srighanthan, Jeevitha
    Murphy, Joan
    Finch, Amy
    Kotsopoulos, Joanne
    Bernardini, Marcus
    Jacobson, Michelle
    Ene, Gabrielle E. V.
    Ho, Irene
    Cohen, Suzanne
    Harvey, Paula
    Rosen, Barry
    Narod, Steven
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 361 - 361
  • [49] The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: Is the evidence sufficient to change practice?
    Brand, Alison H.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2011, 51 (04): : 296 - 300
  • [50] Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer
    Madalinska, JB
    Hollenstein, J
    Bleiker, E
    van Beurden, M
    Valdimarsdottir, HB
    Massuger, LF
    Gaarenstroom, KN
    Mourits, MJE
    Verheijen, RHM
    van Dorst, EBL
    van der Putten, H
    van der Velden, K
    Boonstra, H
    Aaronson, NK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6890 - 6898